Edgewood Management Portfolio holdings
AUM
$31.5B
This Quarter Return
+33.46%
1 Year Return
+19.46%
3 Year Return
+128.01%
5 Year Return
+144.65%
10 Year Return
+626.11%
AUM
$41.4B
AUM Growth
+$11.3B
(+37%)
Cap. Flow
+$2.02B
Cap. Flow
% of AUM
4.88%
Top 10 Holdings %
Top 10 Hldgs %
55.37%
Holding
83
New
4
Increased
23
Reduced
13
Closed
7
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$334M |
| 2 |
Illumina
ILMN
|
$212M |
| 3 |
Visa
V
|
$144M |
| 4 |
American Tower
AMT
|
$128M |
| 5 |
Intuitive Surgical
ISRG
|
$125M |
Top Sells
| 1 |
PayPal
PYPL
|
$277M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$29.5M |
| 3 |
Crown Castle
CCI
|
$722K |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$715K |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
$661K |
Sector Composition
| 1 | Communication Services | 21.43% |
| 2 | Financials | 20.39% |
| 3 | Technology | 19.01% |
| 4 | Healthcare | 12.89% |
| 5 | Real Estate | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Vertex Pharmaceuticals
VRTX
$102B
| $11.3M | 0.03% |
39,088
-2,462
| -6% | -$715K |
|
27
Alphabet (Google) Class C
GOOG
$2.79T
| $9.54M | 0.02% |
134,960
+13,900
| +11% | +$982K |
|
28
Gilead Sciences
GILD
$140B
| $8.25M | 0.02% |
107,282
-239
| -0.2% | -$18.4K |
|
29
AbbVie
ABBV
$374B
| $7.81M | 0.02% |
79,580
| – | – |
|
30
Abbott
ABT
$230B
| $6.75M | 0.02% |
73,814
| – | – |
|
31
Utilities Select Sector SPDR Fund
XLU
$20.8B
| $6.32M | 0.02% |
111,946
-710
| -0.6% | -$40.1K |
|
|
32
SPDR S&P 500 ETF Trust
SPY
$656B
| $5.09M | 0.01% |
16,489
-95,801
| -85% | -$29.5M |
|
33
Prologis
PLD
$103B
| $4.59M | 0.01% |
49,190
| – | – |
|
34
Bristol-Myers Squibb
BMY
$96.7B
| $4.38M | 0.01% |
74,399
| – | – |
|
35
iShares Select Dividend ETF
DVY
$20.6B
| $4.23M | 0.01% |
52,386
-537
| -1% | -$43.4K |
|
36
PepsiCo
PEP
$203B
| $4.12M | 0.01% |
31,159
-140
| -0.4% | -$18.5K |
|
37
Digital Realty Trust
DLR
$55.1B
| $3.99M | 0.01% |
28,101
| – | – |
|
38
Royalty Pharma
RPRX
$15.8B
| $3.4M | 0.01% |
+70,000
| New | +$3.4M |
|
39
Pfizer
PFE
$141B
| $2.84M | 0.01% |
91,411
| – | – |
|
40
Johnson & Johnson
JNJ
$429B
| $2.77M | 0.01% |
19,676
| – | – |
|
41
Sysco
SYY
$38.8B
| $2.19M | 0.01% |
40,074
| – | – |
|
42
Bank of New York Mellon
BK
$73.8B
| $1.48M | ﹤0.01% |
38,307
| – | – |
|
43
Cisco
CSCO
$268B
| $1.36M | ﹤0.01% |
29,238
-450
| -2% | -$21K |
|
44
NextEra Energy, Inc.
NEE
$148B
| $1.35M | ﹤0.01% |
22,400
| – | – |
|
45
Exxon Mobil
XOM
$477B
| $1.25M | ﹤0.01% |
27,966
-76
| -0.3% | -$3.4K |
|
46
Coca-Cola
KO
$297B
| $1.24M | ﹤0.01% |
27,680
| – | – |
|
47
Arrowhead Research
ARWR
$3.84B
| $1.08M | ﹤0.01% |
25,000
+9,000
| +56% | +$389K |
|
48
JPMorgan Chase
JPM
$824B
| $1.07M | ﹤0.01% |
11,414
| – | – |
|
49
Verizon
VZ
$184B
| $1.01M | ﹤0.01% |
18,331
| – | – |
|
50
Merck
MRK
$210B
| $897K | ﹤0.01% |
12,162
| – | – |
|